Illumina to Shutter Connecticut Facility That Builds BeadXpress, Will Consolidate in San Diego | GenomeWeb
NEW YORK (GenomeWeb News) — Illumina plans to shutter its manufacturing operations in Wallingford, Conn., and fold some of the assets from the space into its San Diego facilities, the company said today.
 
The Wallingford site was originally established in connection with the acquisition of CyVera, and has helped Illumina develop and manufacture the BeadXpress system. The platform debuted last month.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.